Sunday, 25 October 2020
News with tag Targus  RSS
Doubt cast on wisdom of targeting 'bad' cholesterol to curb heart disease risk

Added: 03.08.2020 23:41 | 0 views | 0 comments

Setting targets for 'bad' (LDL) cholesterol levels to ward off heart disease and death in those at risk might seem intuitive, but decades of research have failed to show any consistent benefit for this approach, reveals an analysis of the available data.

Tags: Targus
From: https:

Psoriasis drug target offers potential for osteosarcoma

Added: 18.09.2019 14:30 | 0 views | 0 comments

A treatment for psoriasis could be repurposed to treat a rare but aggressive form of youth cancer, new findings suggest.

Tags: Targus, Cancer
From: https:

Some biologic treatments for psoriasis may be safer for patients

Added: 11.05.2019 13:39 | 0 views | 0 comments

Dermatologists found a decreased risk of infection in patients with psoriasis using some of the newer, more targeted medications compared to those taking methotrexate, a drug widely used since the 1960s as a first line treatment for moderate-to-severe psoriasis.

From: https:

People with COPD suffer fewer lung-related problems when treated with targeted lung denervation

Added: 18.09.2018 0:19 | 0 views | 0 comments

First results from a clinical trial of a procedure to open obstructed airways in patients with chronic obstructive pulmonary disease (COPD) have shown that it significantly reduces problems associated with the disease and is safe.

Tags: Targus
From: https:

Insight into potential new strategy to target skin diseases like psoriasis

Added: 04.05.2018 17:23 | 0 views | 0 comments

Research has shown that targeting metabolism in growing cells holds promise for the treatment of skin diseases like psoriasis that are characterized by skin overgrowth resulting from excess cell division, known as hyperproliferation.

Tags: Targus
From: https:

Promising new treatment option for chronic plaque psoriasis

Added: 06.06.2017 15:14 | 0 views | 0 comments

A new study tested the efficacy of tildrakizumab, an antibody that targets only a very specific immune system pathway. More than 60 percent of all patients who received the active medication showed improvement, compared to less than 10 percent of patients who received placebos.

Tags: Targus
From: https:

« Newer articles

Copyright © 2008-2020 USweekly  - all rights reserved